Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice.
about
Insulin-Sensitizing Effects of Omega-3 Fatty Acids: Lost in Translation?(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insightsRole of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and HumansOmega-3 Fatty Acids and Skeletal Muscle HealthSunflower oil supplementation has proinflammatory effects and does not reverse insulin resistance in obesity induced by high-fat diet in C57BL/6 miceEndogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in miceProresolving lipid mediators and diabetic wound healingDietary combination of sucrose and linoleic acid causes skeletal muscle metabolic abnormalities in Zucker fatty rats through specific modification of fatty acid composition.PPARα-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasisSpecific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediatorsMolecular biology for formyl peptide receptors in human diseases.Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway.Lasting effects on body weight and mammary gland gene expression in female mice upon early life exposure to n-3 but not n-6 high-fat diets.Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic.The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.Transgenic increase in N-3/n-6 Fatty Acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in miceResolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.Lipoxins as biomarkers of lupus and other inflammatory conditionsA protective lipidomic biosignature associated with a balanced omega-6/omega-3 ratio in fat-1 transgenic miceRegulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs.Obesity, immunomodulation and chronic kidney disease.Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fatSelf-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNAMolecular targets related to inflammation and insulin resistance and potential interventionsImpact of Obesity and Metabolic Syndrome on Immunity.Proresolution therapy for the treatment of delayed healing of diabetic wounds.Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.Macrophage Proresolving Mediators-the When and Where.Maternal Diet Supplementation with n-6/n-3 Essential Fatty Acids in a 1.2 : 1.0 Ratio Attenuates Metabolic Dysfunction in MSG-Induced Obese Mice.Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseasesThe role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis.Potential role of omega-3-derived resolution mediators in metabolic inflammation.Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome.Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from childhood through to adulthood.18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling.Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis.Genome-wide screen for serum microRNA expression profile in mfat-1 transgenic mice.Co-expression of mFat-1 and pig IGF-1 genes by recombinant plasmids in modified chitosan nanoparticles and its synergistic effect on mouse immunity.Pro-Resolving Mediators in Regulating and Conferring Macrophage Function.fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
P2860
Q26748802-C99E5A2F-6BA2-4B79-82BB-ADE071FF7241Q27013554-42239ADA-8982-4257-B6CA-7E4D1951EFA9Q28075256-AC7E01B1-3FFA-49CA-9F04-FB4678B2D55DQ28084892-4B3D788C-60EE-410C-AC76-282D15BBADE4Q28388533-C7344DAD-2E97-4298-9591-7BB553804D46Q33631964-A78D48E5-89B0-4170-936D-1FF8C8D7E05FQ33683848-C2CAFAD9-B7C4-4D1F-9711-507B0FAD514AQ33832051-186B9065-FAF2-4F60-9681-8F8D35826CB7Q33832975-98D88CAE-54FF-4D0A-863C-B8C89B038503Q34294883-988F85CF-E346-4E83-A384-124D419B2A06Q34327503-E8D587A7-97FC-4674-884C-EE7223C2E5B6Q34446920-9C67C84A-2FC4-4929-ADD8-CAA7C6728DA8Q34586113-35243A55-9CBF-47A2-B2D1-BD29B49D3AC1Q34654705-D89F947D-8A0A-4932-A189-E666A8DD01F0Q34776005-B64C860A-16BE-4F88-9C15-3EF657281984Q34795140-58B49B74-ADF3-4C7D-B2C9-73EABE7E1D04Q35043902-CC10C256-2370-4C03-8852-01126321BCB2Q35044584-3AA2D294-52B7-4B3F-A496-9022A8FE1FD7Q35156337-77C30E8E-8098-4BB5-81AA-2D7E9A6CFBD4Q35332874-FB3718F3-1F6D-4893-B24E-6A02C21408E1Q35640634-BCCD1A77-EC31-4F83-8685-5986EEEF490CQ36179560-687273B1-AFEB-4C52-A392-66509F5A6ED5Q36210558-20060F7C-9BE9-4465-9CD2-A324D86D6B1AQ36294297-360F1616-0E10-476B-9426-2A6FFF09CF97Q36476998-19E01148-AA93-4AFB-8B04-0BD5D0169A59Q36560613-21302EC4-90C2-48A1-BE05-2652FA14A0F3Q36867543-15B64024-E165-44FA-BEF3-546620A2576BQ37041858-4A03E172-D667-456D-A84C-D5F4A5A898B2Q37512706-5A78A3B8-46C1-4DDA-AAE0-C171B445C5BFQ37627490-93AB8F6D-9FB8-4D7F-89DB-E506AB3B332CQ38054491-6E615E37-06D4-472B-B05F-A9E7494A091BQ38182454-41DB5A2D-A734-4F04-A692-972359E52118Q38261195-DDB958A2-8865-42CF-847F-862E65C30644Q38758088-B1911CEF-8E96-419F-902B-D37061B6D5B8Q41810714-06088539-2BD0-4741-83BA-25A5EF282FCBQ42370007-8ED4854B-E217-4AB1-8856-1542376974A6Q46873471-E8183877-3158-48AF-A2CB-399CC4EAD582Q47103131-42283B07-83D1-48C5-A9E2-D96A8B17C96CQ47104000-D264185F-451A-45F1-9E28-8057BBD7E3AEQ47708201-6DD5F1DA-8A63-4F3F-BDD7-05540B2E8E61
P2860
Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@ast
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@en
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@nl
type
label
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@ast
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@en
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@nl
prefLabel
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@ast
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@en
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@nl
P2093
P2860
P921
P356
P1433
P1476
Transgenic restoration of long ...... sistance in high-fat-fed mice.
@en
P2093
André Marette
Jing X Kang
Makoto Arita
Ryo Taguchi
P2860
P304
P356
10.2337/DB10-0054
P407
P577
2010-09-14T00:00:00Z